Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAllegra

    Allegra

    Jump to

    • Dr Reddy's launches generic version of Allegra in US

      The Hyderabad-based drug firm said it has introduced Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg extended release tablets in the US market.

    • Espirito Santo Sec's health forecast for 3 pharma stocks

      While the market has been weak, the pharma sector has remained steadfastly resilient. Chirag Talati, Pharma Analyst, Espirito Santo Securities talks about what is making news in the pharma space.

    • To improve market share, position in Germany: Dr Reddy's

      GV Prasad, Vice Chairman and CEO, Dr Reddys Laboratories in an interview with CNBC-TV18 spoke about the quarterly numbers of the company and the road ahead.

    • Dr Reddy's launches generic Allegra drug in US

      India's No 2 drugmaker Dr. Reddy's Laboratories said on Thursday it has launched its over-the-counter Fexofenadine HCl tablets, a generic version of Sanofi Aventis' antihistamine drug Allegra.

    • Dr Reddy's launches generic Allegra drug in US

      Having won a legal tussle, Dr Reddy's Laboratories on Thursday finally launched its generic Allegra tablets, Fexofenadine HCl, in the US market. DRL will market the over-the-counter product under store brand labels in the US market.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347